Conditions: Primary Open Angle Glaucoma Ocular Hypertension Pigmentary Glaucoma Pseudoexfoliative Glaucoma
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 176
Healthy volunteers: no

Brief summary:
This study will evaluate the safety and efficacy of PF 03187207.

Detailed description:

Arms:
arm 1: One drop of each, once daily in study eye for 28 days arm 2: One drop of each, once daily in study eye for 28 days

Interventions: intervention 1: PF-03187207 and Latanoprost Vehicle intervention 2: Latanoprost 0.005% and PF-03187207 Vehicle
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: